CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma [Phase 1]
Summary
Phase 1 study of RO5045337 in combination with doxorubicin for soft tissue sarcoma has completed enrollment and a status update was provided.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Sarcoma | Phase 1 | Status: COMPLETED